Top

Published in:

01-11-2018 | Review

Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis

Authors: P. Szafors, H. Che, T. Barnetche, J. Morel, C. Gaujoux-Viala, B. Combe, C. Lukas

Published in: Osteoporosis International | Issue 11/2018

Abstract

Inflammatory bowel diseases (IBDs) are associated with a decreased bone mineral density, but the impact on fractures is unknown. In our study, global risk of fracture is increased for patients with IBDs versus controls. This result will help to determine the appropriate assessment with early screening and management of osteoporosis. Inflammatory bowel diseases (IBDs), such as Crohn’s disease (CD) and ulcerative colitis (UC), are associated with a decreased bone mineral density (BMD). However, the impact on fracture risk is unknown and data are contradictory across studies. In this systematic review and meta-analysis, we aimed to assess the risk of fracture and presence of low BMD in patients with IBDs compared to healthy controls. A systematic search of literature was conducted of MEDLINE, EMBASE, the Cochrane library and abstracts from appropriate scientific congresses. Studies were selected if they compared the incidence of fractures and/or BMD measurement by dual-energy X-ray absorptiometry in patients with IBDs and healthy sex- and age-matched controls. Data were extracted by two independent investigators. Meta-analysis was performed with the inverse variance approach to estimate pooled odds ratios (ORs) and risk ratios (RRs) with their 95% confidence intervals (CIs). Twenty-four studies met the inclusion criteria. On the basis of nine studies, global risk of fracture was increased for patients with IBDs versus controls (RR = 1.38, 95% CI 1.11–1.73; p = 0.005). Fracture risk with IBDs was significantly increased for vertebral fractures (OR = 2.26, 95% CI 1.04–4.90; p < 0.001), but not for any other site. The analysis of 16 studies evaluating BMD showed a significant decrease in mean BMD and Z-scores for IBD patients versus controls at all sites. In our meta-analysis, patients with IBDs have an increased risk of fractures, especially in the spine, and significant decreased BMD at all sites, which suggests the need for identifying high-risk individuals among this population.

Available only for authorised users

Vegh Z, Kurti Z, Lakatos PL (2017) Epidemiology of inflammatory bowel diseases from West to East. J Dig Dis 18:92–98CrossRef

Rothfuss KS, Stange EF, Herrlinger KR (2006) Manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 12:4819–4831CrossRef

Von Tirpitz C, Pischulti G, Klaus J et al (1999) Pathological bone density in chronic inflammatory bowel diseases—prevalence and risk factors. Z Gastroenterol 37:5–12

Ali T, Lam D, Bronze M (2009) Osteoporosis in inflammatory bowel disease. Am J Med 122:599–605CrossRef

Vazquez MA, Lopez E, Montoya MJ et al (2012) Vertebral fractures in patients with inflammatory bowel disease compared with a healthy population: a prospective case–control study. Gastroenterology 12:12–47

Bernstein CN, Blanchard JF, Leslie W et al (2000) The incidence of fracture among patients with inflammatory bowel disease. Ann Intern Med 133:796–799CrossRef

Vestergaard P, Mosekilde L (2002) Fracture risk in patients with celiac disease, Crohn’s disease and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 156:1–10CrossRef

Card T, West J, Hubbard R, Logan RF (2004) Hip fractures in patients with inflammatory bowel disease and their relationship to corticosteroid use: a population based-cohort study. Gut 53:251–255CrossRef

Vestergaard P (2004) Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med 95:469–480PubMed

10.

Zeng X, Zhang Y, Kwong J et al (2015) The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta-analysis, and clinical practice guideline: a systematic review. J Evid-Based Med 8:2–10CrossRef

11.

Tsai MS, Lin CL, Tu YK, Lee PH, Kao CH (2015) Risks and predictor of osteoporosis in patients with inflammatory bowel diseases in an Asian population: a nationwide population-based cohort study. Int J Clin Pract 69:235–241CrossRef

12.

De Silva AP, Karunanayake AL, Dissanayaka TG et al (2009) Osteoporosis in adult Sri Lankan inflammatory bowel disease patients. World J Gastroenterol 15:3528–3531CrossRef

13.

Pluskiewicz W, Zdrzalek J, Karasek D (2009) Spine bone mineral density and VDR polymorphism in subject with ulcerative colitis. J Bone Miner Metab 27:567–573CrossRef

14.

Loftus EV, Achenbach SJ, Sandborn W et al (2003) Risk of fracture in ulcerative colitis: a population-based study from Olmsted Country, Minnesota. Clin Gastroenterol Hepatol 1:465–473CrossRef

15.

Loftus EV, Crowson CS, Sandborn WJ et al (2002) Long-term fracture risk in patients with Crohn’s disease: a population-based study in Olmsted Country, Minnesota. Gastroenterology 123:468–475CrossRef

16.

Vestergaard P, Krogh K, Laurberg S et al (2000) Fracture risk is increased in Crohn’s disease, but not in ulcerative colitis. Gut 46:176–181CrossRef

17.

Krela-Kazmierczak I, Kaczmarek-Ryś M, Szymczak A et al (2016) Bone metabolism and the c.-223C>T polymorphism in the D’UTR region of the osteoprotegerin gene in patients with inflammatory bowel disease. Calcif Tissue Int 99:616–624CrossRef

18.

Sugimoto K, Ikeya K, al LT (2016) An increased serum N-terminal telopeptide of type I collagen, a biochemical marker of increased bone resorption, is association with infliximab therapy in patients with Crohn’s disease. Dig Dis Sci 61:99–106CrossRef

19.

Cravo M, Geurreiro CS, Dos Santos PM et al (2010) Risk factors for metabolic bone disease in Crohn’s disease patients. Inflamm Bowel Dis 16:2117–2124CrossRef

20.

Khadgawat R, Makharia GK, Puri K (2008) Evaluation of bone mineral density among patients with inflammatory bowel disease in a tertiary care setting in India. Indian J Gastroenterol 27:103–106PubMed

21.

Souza HN, Lora FL, Kulak CA et al (2008) Low levels of 25-hydroxyvitamin D(25OHD) in patients with inflammatory bowel disease and its correlation with bone mineral density. Arq Bras Endocrinol Metabol 52:684–691CrossRef

22.

Haugeberg G, Vetvik K, Stallemo A et al (2001) Bone density reduction in patients with Crohn disease and associations with demographic and disease variables: cross-sectional data from a population-based study. Scand J Gastroenterol 36:759–765CrossRef

23.

Schoon EJ, Blok BM, Geerling BJ, Russel MG, Stockbrügger RW, Brummer R–JM (2000) Bone mineral density in patients with recently diagnosed inflammatory bowel disease. Gastroenterology 119:1203–1208CrossRef

24.

Ulivieri FM, Lisciandrano D, Ranzi T et al (2000) Bone mineral density and body composition in patients with ulcerative colitis. Am J Gastroenterol 95:1941–1944CrossRef

25.

Dinca M, Fries W, Luisetto G et al (2000) Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 94:1292–1297CrossRef

26.

Fries W, Dinca M, Luisetto G, Peccolo F, Bottega F, Martin A (1998) Calcaneal ultrasound bone densitometry in inflammatory bowel disease—a comparison with double X-ray densitometry of the lumbar spine. Am J Gastroenterol 93:2339–2344PubMed

27.

Reed CA, Nichols DL, Bonnick SL, DiMarco NM (1998) Bone mineral density and dietary intake in patients with Crohn’s disease. J Clin Densitom 1:33–40CrossRef

28.

Jahnsen J, Falch JA, Aadland E, Mowinckel P (1997) Bone mineral density is reduced in patients with Crohn’s disease but not in ulcerative colitis: a population-based cohort study. Gut 40:313–319CrossRef

29.

Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK (1995) A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 37:71–76CrossRef

30.

Martin A, Fries W, Luisetto G, Mussolin L, Plebani M, Giacomin D, Naccarato R (1994) Bone density and calcium metabolism in patients with long-standing, quiescent Crohn’s disease. Eur J Gastroenterol Hepatol 6:611–616CrossRef

31.

Briot K, Geusens P, Em Bultink I, Lems WF, Roux C (2017) Inflammatory disease and bone fragility. Osteoporos Int 28:3301–3314. https://doi.org/10.1007/s00198-017-4189-7 CrossRef

32.

Tilg H, Moschen AR, Kaser A, Pines A, Dotan I (2008) Gut, inflammation and osteoporosis: basic and clinical concepts. Gut 57:684–694CrossRef

33.

Targownik LE, Bernstein CN, Leslie WD (2014) Risk factor and management of osteoporosis in inflammatory bowel disease. Curr Opin Gastroenterol 30:168–174CrossRef

34.

Bernstein CN, Blanchard JF, Metge C, Yogendran M (2003) The association between corticosteroid use and development of fractures among IBD patients in a population-based database. Am J Gastroenterol 98:1797–1801CrossRef

35.

Genant H, Grampp S, Gluer C et al (1994) Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9:1503–1514CrossRef

Title: Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis
Authors: P. Szafors
H. Che
T. Barnetche
J. Morel
C. Gaujoux-Viala
B. Combe
C. Lukas
Publication date: 01-11-2018
Publisher: Springer London
Published in: Osteoporosis International / Issue 11/2018
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-018-4586-6

At a glance: The STEP trials

Springer Medicine

Risk of fracture and low bone mineral density in adults with inflammatory bowel diseases. A systematic literature review with meta-analysis

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2018

Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands

Post-traumatic stress disorder and incident fractures in the Danish population

Role of musculoskeletal disorders in falls of postmenopausal women

A modification and validation of quantitative morphometry classification system for osteoporotic vertebral compressive fractures in mainland Chinese

Correction to: Differences in bone quality and strength between Asian and Caucasian young men

Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older